PATRICIA CARMEN
MUÑOZ GARCÍA
Catedrática de universidad
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (21)
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Validation of an expanded, in-house library and an optimized preparation method for the identification of fungal isolates using MALDI-TOF mass spectrometry
Medical mycology, Vol. 61, Núm. 4
2022
-
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2021
-
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain
Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
Linezolid for infective endocarditis: A structured approach based on a national database experience
Medicine (United States), Vol. 100, Núm. 51
2017
-
Endocarditis caused by anaerobic bacteria
Anaerobe, Vol. 47, pp. 33-38
2015
-
Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study
Medicine (United States), Vol. 94, Núm. 43
-
Left-sided infective endocarditis in patients with liver cirrhosis
Journal of Infection, Vol. 71, Núm. 6, pp. 627-641
-
Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: Safety analysis of a multicenter randomized trial
Clinical Infectious Diseases, Vol. 60, Núm. 11, pp. 1642-1649
2014
-
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort
Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396
2012
-
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort
Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603
-
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study
Transplant International, Vol. 25, Núm. 12, pp. 1275-1281
2009
-
Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients
Transplantation, Vol. 87, Núm. 3, pp. 424-435
-
Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the resitra (spanish network of infection in transplantation) cohort
Clinical Infectious Diseases, Vol. 48, Núm. 12, pp. 1657-1665
2008
-
Donor infection and transmission to the recipient of a solid allograft
American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425
-
Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation
Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882
2007
-
Advances in lower respiratory tract infections in critically ill patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 47-57
-
Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections?
Journal of Clinical Microbiology, Vol. 45, Núm. 9, pp. 2765-2769